Deb, B.; Puttamallesh, V.N.; Gondkar, K.; Thiery, J.P.; Gowda, H.; Kumar, P.
Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma. J. Clin. Med. 2019, 8, 703.
https://doi.org/10.3390/jcm8050703
AMA Style
Deb B, Puttamallesh VN, Gondkar K, Thiery JP, Gowda H, Kumar P.
Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma. Journal of Clinical Medicine. 2019; 8(5):703.
https://doi.org/10.3390/jcm8050703
Chicago/Turabian Style
Deb, Barnali, Vinuth N. Puttamallesh, Kirti Gondkar, Jean P. Thiery, Harsha Gowda, and Prashant Kumar.
2019. "Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma" Journal of Clinical Medicine 8, no. 5: 703.
https://doi.org/10.3390/jcm8050703
APA Style
Deb, B., Puttamallesh, V. N., Gondkar, K., Thiery, J. P., Gowda, H., & Kumar, P.
(2019). Phosphoproteomic Profiling Identifies Aberrant Activation of Integrin Signaling in Aggressive Non-Type Bladder Carcinoma. Journal of Clinical Medicine, 8(5), 703.
https://doi.org/10.3390/jcm8050703